Hello, everyone. I just wanted to highlight something that changed recently due to a methodological modification regarding cohort designation in PPMI. This modification took place on August 28, 2024, so it may still be relatively new to most of us.
Prior to this modification, PPMI provided a specific document designating patients within their cohorts (such as PD, Healthy Controls, etc.). This document was intended to be used separately to identify patients in their respective cohorts and was updated by a committee from the study group. However, following this recent review, we now need to identify patients using the “Participant Status” dataset, which is located under the “Subject Characteristics” heading in LONI.
Additonally, PPMI is now introducing the “Neuronal Synuclein Disease (NSD) Categorization”. As explained in the most recent Data User Guide:
The overall NSD category is based on both the presence of pathologic neuronal α-synuclein (S) and dopaminergic neuronal dysfunction (D).
Here is an image extracted from the most recent Data User Guide explaining this new and optional classification:
@jgottesman @gginnan, due to this change, we should review the instructions written in our Getting Started With Parkinson’s Disease Data. I can make these changes to the PPMI part, just tell me which document I should edit and the other necessary steps to update the document.